Company
OurView
OurView publishes compounded semaglutide and compounded tirzepatide, from $109 to $129 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from ourviewhealth.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to OurView
We earn nothing from this link. OurView has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Month-to-Month
first month, including the required fees on record · Month-to-Month
Terms
| Pharmacy | OurView's own parent company, an unnamed licensed nationwide pharmacy |
|---|---|
| States | All states except Arkansas, Connecticut, Hawaii, and New Jersey (plus the District of Columbia) |
Not yet checked: membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. The homepage advertises flat pricing of '$99/month Semaglutide' and '$119/month Tirzepatide' with 'No membership fee', but the actual order pages (personalized-glp-1/, personalized-glp-1-gip/) price the month-to-month plan at $109 and $129 respectively — $99/$119 is only reached by paying 3 months upfront ($297/$357 today). Separately, the homepage's 'membership' comparison table shows a third, lower price ('GLP-1 Medication $75' with membership vs '$90' without) that matches neither the $99/$119 headline nor the $109/$129 month-to-month order price, and no page states what the membership itself costs per month. No page checked states whether the medication ships as a vial or a pen, so form is recorded as not-disclosed.
Before you act
Cite this
Treatment Registry. (2026). OurView: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/ourview-health